Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5205810
Max Phase: Preclinical
Molecular Formula: C42H43ClN6O7
Molecular Weight: 779.29
Associated Items:
ID: ALA5205810
Max Phase: Preclinical
Molecular Formula: C42H43ClN6O7
Molecular Weight: 779.29
Associated Items:
Canonical SMILES: CC1(C)[C@H](NC(=O)c2ccc3c(c2)C(=O)N(CCCCCNc2cccc4c2C(=O)N(C2CCC(=O)NC2=O)C4=O)C3)C(C)(C)[C@H]1Oc1ccc(C#N)c(Cl)c1
Standard InChI: InChI=1S/C42H43ClN6O7/c1-41(2)39(42(3,4)40(41)56-26-14-13-24(21-44)29(43)20-26)47-34(51)23-11-12-25-22-48(36(53)28(25)19-23)18-7-5-6-17-45-30-10-8-9-27-33(30)38(55)49(37(27)54)31-15-16-32(50)46-35(31)52/h8-14,19-20,31,39-40,45H,5-7,15-18,22H2,1-4H3,(H,47,51)(H,46,50,52)/t31?,39-,40-
Standard InChI Key: AVEIGDFDRPVARJ-LLUWIFRESA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 779.29 | Molecular Weight (Monoisotopic): 778.2882 | AlogP: 5.46 | #Rotatable Bonds: 12 |
Polar Surface Area: 178.01 | Molecular Species: NEUTRAL | HBA: 9 | HBD: 3 |
#RO5 Violations: 2 | HBA (Lipinski): 13 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 11.59 | CX Basic pKa: 2.26 | CX LogP: 5.20 | CX LogD: 5.20 |
Aromatic Rings: 3 | Heavy Atoms: 56 | QED Weighted: 0.16 | Np Likeness Score: -0.54 |
1. Guo L, Zhou Y, Nie X, Zhang Z, Zhang Z, Li C, Wang T, Tang W.. (2022) A platform for the rapid synthesis of proteolysis targeting chimeras (Rapid-TAC) under miniaturized conditions., 236 [PMID:35397401] [10.1016/j.ejmech.2022.114317] |
Source(1):